pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board



      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications



      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
    • Tag › ranibizumab

    Results of a 12-month follow-up of neovascular age-related macular degeneration after switching an angiogenesis inhibitor in real clinical practice

    Редактор | 2018, Practical medicine 03 (18) Ophthalmology | 10 апреля, 2018

    E.V. BOBYKIN, S.A. KOROTKIKH, R.V. BUSLAEV Ural State Medical University, 3 Repin St., Ekaterinburg, Russian Federation, 620028   Bobykin E.V. ― Cand. Med. Sc., Assistant Professor, Assistant Professor of the Ophthalmology Department, tel. (343) 214-80-00, e-mail: oculist.ev@gmail.com Korotkikh S.A. ― D. Med. Sc., Professor, Head of the Ophthalmology Department, tel. (343) 214-86-67, e-mail: med@usma.ru Buslaev R.V. […]

    Tag: 2018, aflibercept switching, E.V. BOBYKIN, neovascular («wet») age-related macular degeneration, Practical medicine 03 (18) Ophthalmology, R.V. BUSLAEV, ranibizumab, S.A. KOROTKIKH, switch back
    Комментарии к записи Results of a 12-month follow-up of neovascular age-related macular degeneration after switching an angiogenesis inhibitor in real clinical practice отключены

    Anti-VEGF therapy in a specialized budgetary institution (by the data of Penza Regional Eye Hospital)

    Редактор | 2018, Practical medicine 03 (18) Ophthalmology, Офтальмология | 10 апреля, 2018

    S.L. KUZNETSOV1, R.S. GALEYEV2, F.A. ANESYAN3, E.E. BRAZHALOVICH1, K.A. VYAZOVKINA3, D.D. MAKAROVA3 1Penza Institute for Advanced Medical Education ― Branch Campus of the FSBEI FPE RMACPE MOH Russia, 8a Stasov Str., Penza, Russian Federation, 440062 2Penza Regional Eye Hospital, 32 Krasnaya Str., Penza, Russian Federation, 440026 3Medical Institute of Penza State University, 40 Krasnaya Str., […]

    Tag: 2018, aflibercept, anti-VEGF therapy, D.D. MAKAROVA, E.E. BRAZHALOVICH, F.A. ANESYAN, injection index, K.A. VYAZOVKINA, Practical medicine 03 (18) Ophthalmology, R.S. GALEYEV, ranibizumab, S.L. KUZNETSOV
    Комментарии к записи Anti-VEGF therapy in a specialized budgetary institution (by the data of Penza Regional Eye Hospital) отключены

    Clinical and functional outcome of combined treatment for polypoidal choroidal vasculopathy

    Редактор | 2018, Practical medicine 03 (18) Ophthalmology | 10 апреля, 2018

    A.M. MAYOROVA, A.V. DOGA, E.K. PEDANOVA The S. Fyodorov Eye Microsurgery Federal State Institution, 59a Beskudnikovsky Blvd., Moscow, Russian Federation 127486 Contact: Mayorova A.M. ― postgraduate student of Laser Retinal Surgery Department, tel. (499) 488-84-30, e-mail: ammayorova@gmail.com Doga A.V. ― D. Med. Sc., Professor, Deputy Director General of Scientific and Clinical Work, tel. (499) 488-89-93, […]

    Tag: 2018, A.M. MAYOROVA, A.V. DOGA, chlorine e6, E.K. PEDANOVA, photodynamic therapy, polypoidal choroidal vasculopathy, Practical medicine 03 (18) Ophthalmology, ranibizumab
    Комментарии к записи Clinical and functional outcome of combined treatment for polypoidal choroidal vasculopathy отключены

    Duration of anti-VEGF therapy of neovascular macular diseases in real clinical practice

    Редактор | 2017, Practical medicine 09 (17) Ophthalmology. Part 2 | 6 сентября, 2017

    E.V. BOBYKIN, O.V. MOROZOVA, R.V. BUSLAEV Ural State Medical University, 3 Repina Str., Yekaterinburg, Russian Federation, 620028  Bobykin E.V. — Cand. Med. Sc., Associate Professor of the Ophthalmology Department, tel. (343) 214-80-00, e-mail: oculist.ev@gmail.com Morozova O.V. — ophthalmologist, applicant of the Ophthalmology Department, tel. (343) 214-80-00, e-mail: oculist.ev@gmail.com Buslaev R.V. — clinical resident of the […]

    Tag: 2017, anti-VEGF therapy, duration of treatment, E.V. BOBYKIN, neovascularization, O.V. MOROZOVA, Practical medicine 09 (17) Ophthalmology. Part 2, R.V. BUSLAEV, ranibizumab, real clinical practice
    Комментарии к записи Duration of anti-VEGF therapy of neovascular macular diseases in real clinical practice отключены

    Immediate results of switching the anti-VEGF agent in the treatment of neovascular age-related macular degeneration in clinical practice

    Редактор | 2017, Original articles, Practical medicine 03 (17) Ophthalmology | 27 апреля, 2017

    E.V. BOBYKIN, S.A. KOROTKIKH Ural State Medical University, 3 Repin Str., Yekaterinburg, Russian Federation, 620028  Bobykin E.V. ― Cand. Med. Sc., Associate Professor of the Department of Ophthalmology, tel. +7-912-240-03-63, e-mail: oculist.ev@gmail.com Korotkikh S.A. ― D. Med. Sc., Professor, Head of the Department of Ophthalmology, tel. (343) 214-86-67, e-mail: med@usma.ru Early results of the switching […]

    Tag: 03, 2017, aflibercept, E.V. BOBYKIN, neovascular («wet») age-related macular degeneration, ranibizumab, S.A. KOROTKIKH, switching
    Комментарии к записи Immediate results of switching the anti-VEGF agent in the treatment of neovascular age-related macular degeneration in clinical practice отключены
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©